Annual FCF
-$14.78 M
+$6.72 M+31.27%
December 31, 2023
Summary
- As of February 8, 2025, COCP annual free cash flow is -$14.78 million, with the most recent change of +$6.72 million (+31.27%) on December 31, 2023.
- During the last 3 years, COCP annual FCF has fallen by -$4.71 million (-46.81%).
- COCP annual FCF is now -48692.08% below its all-time high of -$30.30 thousand, reached on December 31, 2009.
Performance
COCP Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly FCF
-$5.12 M
-$1.42 M-38.50%
September 30, 2024
Summary
- As of February 8, 2025, COCP quarterly free cash flow is -$5.12 million, with the most recent change of -$1.42 million (-38.50%) on September 30, 2024.
- Over the past year, COCP quarterly FCF has dropped by -$2.44 million (-91.09%).
- COCP quarterly FCF is now -357.05% below its all-time high of $1.99 million, reached on March 31, 2019.
Performance
COCP Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM FCF
-$16.72 M
-$2.44 M-17.11%
September 30, 2024
Summary
- As of February 8, 2025, COCP TTM free cash flow is -$16.72 million, with the most recent change of -$2.44 million (-17.11%) on September 30, 2024.
- Over the past year, COCP TTM FCF has dropped by -$414.00 thousand (-2.54%).
- COCP TTM FCF is now -112101.34% below its all-time high of -$14.90 thousand, reached on March 31, 2008.
Performance
COCP TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
COCP Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +31.3% | -91.1% | -2.5% |
| 3 y3 years | -46.8% | -4.4% | +22.3% |
| 5 y5 years | -77.7% | -4.4% | +22.3% |
COCP Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -15.8% | +31.3% | -91.1% | +42.9% | -30.9% | +26.0% |
| 5 y | 5-year | -765.6% | +31.3% | -316.2% | +42.9% | -878.8% | +26.0% |
| alltime | all time | <-9999.0% | +31.3% | -357.1% | +42.9% | <-9999.0% | +26.0% |
Cocrystal Pharma Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$5.12 M(+38.5%) | -$16.72 M(+17.1%) |
| Jun 2024 | - | -$3.70 M(-18.0%) | -$14.28 M(-11.5%) |
| Mar 2024 | - | -$4.51 M(+33.3%) | -$16.14 M(+9.2%) |
| Dec 2023 | -$14.78 M(-31.3%) | -$3.38 M(+26.3%) | -$14.78 M(-9.3%) |
| Sep 2023 | - | -$2.68 M(-51.8%) | -$16.30 M(-27.8%) |
| Jun 2023 | - | -$5.56 M(+76.2%) | -$22.59 M(+8.9%) |
| Mar 2023 | - | -$3.16 M(-35.7%) | -$20.75 M(-3.5%) |
| Dec 2022 | -$21.51 M(+68.4%) | -$4.91 M(-45.3%) | -$21.51 M(+10.1%) |
| Sep 2022 | - | -$8.97 M(+140.9%) | -$19.53 M(+22.3%) |
| Jun 2022 | - | -$3.72 M(-4.8%) | -$15.97 M(+7.3%) |
| Mar 2022 | - | -$3.91 M(+33.4%) | -$14.89 M(+16.6%) |
| Dec 2021 | -$12.77 M(+26.8%) | -$2.93 M(-45.8%) | -$12.77 M(+4.5%) |
| Sep 2021 | - | -$5.41 M(+104.9%) | -$12.22 M(+23.5%) |
| Jun 2021 | - | -$2.64 M(+47.0%) | -$9.90 M(+3.3%) |
| Mar 2021 | - | -$1.79 M(-24.6%) | -$9.58 M(-4.8%) |
| Dec 2020 | -$10.07 M(+489.6%) | -$2.38 M(-22.7%) | -$10.07 M(+12.9%) |
| Sep 2020 | - | -$3.08 M(+32.4%) | -$8.92 M(+22.6%) |
| Jun 2020 | - | -$2.33 M(+2.0%) | -$7.28 M(+21.6%) |
| Mar 2020 | - | -$2.28 M(+85.3%) | -$5.98 M(+250.2%) |
| Dec 2019 | -$1.71 M(-79.5%) | -$1.23 M(-14.4%) | -$1.71 M(-30.6%) |
| Sep 2019 | - | -$1.44 M(+39.3%) | -$2.46 M(-22.6%) |
| Jun 2019 | - | -$1.03 M(-151.8%) | -$3.18 M(-25.0%) |
| Mar 2019 | - | $1.99 M(-200.4%) | -$4.24 M(-49.0%) |
| Dec 2018 | -$8.32 M(+19.8%) | -$1.99 M(-8.0%) | -$8.32 M(+5.1%) |
| Sep 2018 | - | -$2.16 M(+3.1%) | -$7.91 M(-0.4%) |
| Jun 2018 | - | -$2.09 M(+0.5%) | -$7.94 M(+14.4%) |
| Mar 2018 | - | -$2.08 M(+31.8%) | -$6.94 M(-0.0%) |
| Dec 2017 | -$6.94 M(-52.8%) | -$1.58 M(-27.7%) | -$6.94 M(-9.4%) |
| Sep 2017 | - | -$2.19 M(+100.2%) | -$7.67 M(-11.3%) |
| Jun 2017 | - | -$1.09 M(-47.6%) | -$8.64 M(-32.1%) |
| Mar 2017 | - | -$2.08 M(-9.5%) | -$12.73 M(-13.4%) |
| Dec 2016 | -$14.71 M | -$2.30 M(-27.1%) | -$14.71 M(-5.5%) |
| Sep 2016 | - | -$3.16 M(-39.1%) | -$15.56 M(-1.4%) |
| Jun 2016 | - | -$5.18 M(+27.7%) | -$15.79 M(+20.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2016 | - | -$4.06 M(+28.4%) | -$13.15 M(+23.4%) |
| Dec 2015 | -$10.66 M(+77.1%) | -$3.16 M(-6.6%) | -$10.66 M(+15.2%) |
| Sep 2015 | - | -$3.39 M(+33.1%) | -$9.25 M(+32.0%) |
| Jun 2015 | - | -$2.54 M(+62.7%) | -$7.01 M(+20.8%) |
| Mar 2015 | - | -$1.56 M(-10.9%) | -$5.80 M(-3.6%) |
| Dec 2014 | -$6.02 M(+63.1%) | -$1.76 M(+53.6%) | -$6.02 M(+18.6%) |
| Sep 2014 | - | -$1.14 M(-14.6%) | -$5.07 M(+4.0%) |
| Jun 2014 | - | -$1.34 M(-24.8%) | -$4.88 M(+8.0%) |
| Mar 2014 | - | -$1.78 M(+119.5%) | -$4.52 M(+22.4%) |
| Dec 2013 | -$3.69 M(+111.9%) | -$811.00 K(-14.5%) | -$3.69 M(+38.6%) |
| Sep 2013 | - | -$949.00 K(-3.0%) | -$2.66 M(+96.5%) |
| Jun 2013 | - | -$978.00 K(+2.7%) | -$1.36 M(+163.2%) |
| Mar 2013 | - | -$952.00 K(-540.9%) | -$514.90 K(-70.4%) |
| Dec 2012 | -$1.74 M(+74.7%) | $215.90 K(-39.8%) | -$1.74 M(-36.8%) |
| Sep 2012 | - | $358.70 K(-360.9%) | -$2.75 M(+12.3%) |
| Jun 2012 | - | -$137.50 K(-93.7%) | -$2.45 M(-8.7%) |
| Mar 2012 | - | -$2.18 M(+173.0%) | -$2.69 M(+169.7%) |
| Dec 2011 | -$996.40 K(+61.0%) | -$797.80 K(-220.7%) | -$996.30 K(+1164.3%) |
| Sep 2011 | - | $661.10 K(-277.5%) | -$78.80 K(-91.7%) |
| Jun 2011 | - | -$372.50 K(-23.5%) | -$953.60 K(-13.3%) |
| Mar 2011 | - | -$487.10 K(-506.9%) | -$1.10 M(+77.7%) |
| Dec 2010 | -$619.00 K(+1942.9%) | $119.70 K(-156.0%) | -$619.00 K(-16.6%) |
| Sep 2010 | - | -$213.70 K(-58.8%) | -$741.80 K(+40.0%) |
| Jun 2010 | - | -$518.70 K(+8133.3%) | -$529.90 K(+2071.7%) |
| Mar 2010 | - | -$6300.00(+103.2%) | -$24.40 K(-19.7%) |
| Dec 2009 | -$30.30 K(-12.4%) | -$3100.00(+72.2%) | -$30.40 K(-5.0%) |
| Sep 2009 | - | -$1800.00(-86.4%) | -$32.00 K(-10.9%) |
| Jun 2009 | - | -$13.20 K(+7.3%) | -$35.90 K(+12.2%) |
| Mar 2009 | - | -$12.30 K(+161.7%) | -$32.00 K(-7.5%) |
| Dec 2008 | -$34.60 K(+1.2%) | -$4700.00(-17.5%) | -$34.60 K(+15.7%) |
| Sep 2008 | - | -$5700.00(-38.7%) | -$29.90 K(+23.6%) |
| Jun 2008 | - | -$9300.00(-37.6%) | -$24.20 K(+62.4%) |
| Mar 2008 | - | -$14.90 K | -$14.90 K |
| Dec 2007 | -$34.20 K | - | - |
FAQ
- What is Cocrystal Pharma annual free cash flow?
- What is the all time high annual FCF for Cocrystal Pharma?
- What is Cocrystal Pharma annual FCF year-on-year change?
- What is Cocrystal Pharma quarterly free cash flow?
- What is the all time high quarterly FCF for Cocrystal Pharma?
- What is Cocrystal Pharma quarterly FCF year-on-year change?
- What is Cocrystal Pharma TTM free cash flow?
- What is the all time high TTM FCF for Cocrystal Pharma?
- What is Cocrystal Pharma TTM FCF year-on-year change?
What is Cocrystal Pharma annual free cash flow?
The current annual FCF of COCP is -$14.78 M
What is the all time high annual FCF for Cocrystal Pharma?
Cocrystal Pharma all-time high annual free cash flow is -$30.30 K
What is Cocrystal Pharma annual FCF year-on-year change?
Over the past year, COCP annual free cash flow has changed by +$6.72 M (+31.27%)
What is Cocrystal Pharma quarterly free cash flow?
The current quarterly FCF of COCP is -$5.12 M
What is the all time high quarterly FCF for Cocrystal Pharma?
Cocrystal Pharma all-time high quarterly free cash flow is $1.99 M
What is Cocrystal Pharma quarterly FCF year-on-year change?
Over the past year, COCP quarterly free cash flow has changed by -$2.44 M (-91.09%)
What is Cocrystal Pharma TTM free cash flow?
The current TTM FCF of COCP is -$16.72 M
What is the all time high TTM FCF for Cocrystal Pharma?
Cocrystal Pharma all-time high TTM free cash flow is -$14.90 K
What is Cocrystal Pharma TTM FCF year-on-year change?
Over the past year, COCP TTM free cash flow has changed by -$414.00 K (-2.54%)